RxDoctor Payments Data
★ My doctorsLook up a doctor →

Gary Pepper

Endocrinology, Diabetes & Metabolism · Jupiter, FLNPI 1881608545

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (35.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 52 manufacturers reported payments, led by Acella Pharmaceuticals, LLC at 34.7% of the total. Reporting peaked in 2020 at $10,793 and has fallen 72.9% since, to $2,925 in 2024.

$31,889in general payments, 2019–2025

Across 595 payments — averaging $53.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acella Pharmaceuticals, LLC$11K
  • AbbVie$10K
  • Novo Nordisk$1K
  • Sanofi-aventis U.S. LLC$1K
  • Tosoh Bioscience, Inc.$1K
  • AstraZeneca$757
  • plus $6K from 46 others
$60,637in research payments, 2019–2025

Across 26 payments — averaging $2332.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endo Pharmaceuticals Inc.$61K

What the payments were for

  • Consulting fees$11,24335%
  • Speaking & faculty fees$9,38829%
  • Food & beverage$10,10532%
  • Education$750%
  • Gifts$1,0783%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Acella Pharmaceuticals, LLC13$11,053
AbbVie22$10,039
Novo Nordisk112$1,428
Sanofi-aventis U.S. LLC63$1,127
Tosoh Bioscience, Inc.2$1,078
AstraZeneca(2 entities)39$757
Lilly USA, LLC37$550
Endo Pharmaceuticals Inc.34$532
Bayer22$490
Mannkind Corporation21$453
Insulet Corporation19$402
Amarin Pharma, Inc.30$378
Amgen(2 entities)19$326
Abbott13$275
Xeris Pharmaceuticals, Inc.16$271
Boehringer Ingelheim8$240
Amneal Pharmaceuticals LLC15$223
Radius Health, Inc.11$213
Valeritas, Inc.9$203
Ipsen Biopharmaceuticals, Inc3$174
Tandem Diabetes Care, Inc.4$166
Lifescan, Inc.7$142
Recordati_rare_diseases_inc.7$135
Medtronic(2 entities)8$125
Merck6$99
Antares Pharma, Inc.6$95
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$87
Shire North American Group Inc4$77
Pfizer3$68
Johnson & Johnson3$62
Alfasigma USA, Inc.4$62
Zealand Pharma US, Inc.3$53
Dexcom, Inc.3$51
Esperion Therapeutics, Inc.3$48
Vivus LLC2$34
EUSA Pharma (US) LLC2$34
Amryt Pharma Holdings Ltd2$34
Quidel Corporation1$32
Ascendis Pharma Endocrinology Inc1$28
BD1$28
Corcept Therapeutics2$25
Companion Medical, Inc.1$25
Novartis1$20
Organogenesis Inc.1$20
Alvogen Inc1$18
Kyowa Kirin, Inc.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$18
Aytu Biopharma, Inc.1$16
Azurity Pharmaceuticals, Inc.1$16
IBSA Pharma Inc.1$15
Cardiovascular Systems Inc.1$12
Currax Pharmaceuticals LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,889 in reported general payments places this provider in the 85th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide11$18,891
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/714$8,484
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$7,578
Nano 2nd Gen Pen NeedlePen Needle, Diabetic27$3,068
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,883
LantusInsulin Glargine,hum.Rec.Anlog12$1,676
Humalog Kwikpen U-100Insulin Lispro12$1,613
SynthroidLevothyroxine Sodium20$1,602
Levothyroxine Sodium86$946
Rosuvastatin Calcium22$392
Metformin Hcl41$264
Simvastatin11$212
Glimepiride15$160
Glipizide13$114
Amlodipine Besylate16$100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$550$18,89111 claims
Sanofi-aventis U.S. LLCLantus$1,127$1,67612 claims
AbbVieSynthroid$10,039$1,60220 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$223$94686 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

Other endocrinology, diabetes & metabolism in Jupiter

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →